Researchers welcome the initiative, but say it doesn’t go far enough to capture the nuance of researcher productivity and ...
Patel discusses the design and patient criteria for the pivotal C-POST trial evaluating adjuvant cemiplimab in high-risk ...
23h
Silver Creek Pharmaceuticals Announces Positive Phase 2 Results for Scp776 in Acute Ischemic Stroke
Key Highlights Scp776 is the first therapy to show clinically meaningful efficacy in late-window stroke patients (treated up to 24 hours after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback